CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-29 | SAYER KEVIN R President, CEO and Chairman | Sale | −220 | $354.00 | $78K | 128,747 |
| 2020-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −239 | $397.49 | $95K | 62,779 |
| 2020-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −149 | $399.62 | $60K | 62,630 |
| 2020-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −70 | $402.61 | $28K | 62,560 |
| 2020-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −170 | $404.91 | $69K | 62,390 |
| 2020-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −173 | $405.99 | $70K | 62,217 |
| 2020-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −195 | $407.02 | $79K | 62,022 |
| 2020-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −83 | $408.00 | $34K | 61,939 |
| 2020-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −247 | $397.49 | $98K | 13,066 |
| 2020-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −156 | $399.63 | $62K | 12,910 |
| 2020-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −74 | $402.57 | $30K | 12,836 |
| 2020-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −6 | $403.49 | $2K | 12,830 |
| 2020-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −213 | $405.07 | $86K | 12,617 |
| 2020-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −263 | $406.45 | $107K | 12,354 |
| 2020-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −68 | $406.93 | $28K | 12,286 |
| 2020-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −83 | $408.00 | $34K | 12,203 |
| 2020-10-15 | FOLETTA MARK G Director | Sale | −42 | $391.48 | $16K | 15,160 |
| 2020-10-15 | FOLETTA MARK G Director | Sale | −120 | $395.02 | $47K | 15,040 |
| 2020-10-15 | FOLETTA MARK G Director | Sale | −255 | $396.51 | $101K | 14,785 |
| 2020-10-15 | FOLETTA MARK G Director | Sale | −375 | $397.41 | $149K | 14,410 |
Page 46 of 55 · 1,082 trades